return to news
  1. Q4 Results Highlights: ITC profit surges over 247%, Sun Pharma's margin rises; board recommends dividend

Q4 Results Highlights: ITC profit surges over 247%, Sun Pharma's margin rises; board recommends dividend

Upstox

5 min read | Updated on May 23, 2025, 07:36 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Together with the interim dividend of ₹6.50 per ordinary share declared on February 6, 2025, ITC's total dividend for the financial year ended 31st March, 2025, would be ₹14.35 per ordinary share of ₹1 each.

card-img

As many as 164 companies will post their earnings number for the fourth quarter of the financial year 2024-25 on Thursday, May 22.

  1. ITC Q4: Board recommends final dividend of ₹7.85 per share

    ITC's board of directors recommended a final dividend of ₹7.85 per equity share of ₹1 each, subject to shareholder approval at the ensuing Annual General Meeting.

    The dividend, if approved, will be paid between Monday, July 28, 2025 and Thursday, July 31, 2025. Further, it fixed Wednesday, May 28, 2025 as the record date.

    Together with the interim dividend of ₹6.50 per ordinary share declared on February 6, 2025, ITC's total dividend for the financial year ended 31st March, 2025 would be ₹14.35 per ordinary share of ₹1 each, the FMCG company said.

    May 22, 2025, 17:34 PM

  2. ITC Q4: Standalone net profit rises three folds to ₹19,562 crore

    • Revenue at ₹18,494.06 crore versus ₹18,290.24 crore, UP 1.11%.
    • Net profit at ₹19,561.57 crore versus ₹5,638.25 crore, UP 247%.

    May 22, 2025, 17:21 PM

  3. Sun Pharma Q4: Board recommends dividend

    Sun Pharma's board of directors recommended a final dividend of ₹5.50 per equity share of ₹1 each, subject to shareholder approval at the ensuing Annual General Meeting.

    It also fixed Monday, July 7, 2025, as the record date for the divided. Further, the dividend, if approved, will be paid on or before Friday, August 8, 2025.

    May 22, 2025, 17:27 PM

  4. Sun Pharma Q4: Consolidated net profit down 19% at ₹2,154 crore

    • Revenue at ₹12,958.8 crore versus ₹11,983 crore, UP 8.1%.
    • Net profit at ₹2,153.9 crore versus ₹2,658.7 crore, DOWN 18.63%.
    • EBITDA at ₹3,715.9 crore versus ₹3,035.15 crore, UP 22.4%.
    • Margin at 28.7% versus 25.3%

    May 22, 2025, 17:13 PM

  5. Honasa Conusmer Q4: Consolidated net profit shrink 18% to ₹25 crore

    • Revenue at ₹533.5 crore versus ₹471 crore, UP 13.3%.
    • Net profit at ₹25 crore versus ₹30 crore, DOWN 17.8%.
    • EBITDA at ₹26.9 crore versus ₹33 crore, DOWN 18.5%.
    • Margin at 5% versus 7%

    May 22, 2025, 16:55 PM

  6. Deepak Fertilizers Q4: Management commentary

    “This year has been challenging yet transformative, marked by strategic actions that boosted growth across all product segments. Our financial performance for FY 2024–25 highlights resilience, innovation, and a strong foundation for future success,” said S.C. Mehta, Chairman and Managing Director of DFPCL.

    “Our shift from a commodity focus to a speciality and solutions-led company is well underway. FY 2025–26 is poised to be a pivotal year—one that will prepare us for a major operational leap, with key capacity expansions nearing completion by H2 FY26. These expansions will elevate us as one of the global leaders in Technical Ammonium Nitrate and Building Block Nitric Acid,” Mehta further said.

    May 22, 2025, 15:31 PM

  7. Deepak Fertilizers Q4: Dividend recommended at ₹10 per share for FY25

    The company’s board has recommended a dividend at the rate of ₹10 per equity share with a face value of ₹10 each for the financial year 2024-2025. The dividend, if declared at the ensuing Annual General Meeting (AGM), will be paid to the shareholders within 30 days of the Annual General Meeting, Deepak Fertilizers said.

    "Further, the Register of Members of the Company will remain closed from Wednesday, 3rd September, 2025, to Tuesday, 9th September, 2025 (both days inclusive) for the purpose of payment of dividend and AGM of the Company," it said.

    May 22, 2025, 15:27 PM

  8. Deepak Fertilizers Q4: Net profit rises 21% YoY; margin shrinks

    • Revenue at ₹2,667.4 crore versus ₹2,086.3 crore, UP 27.9%

    • Net profit at ₹277.9 crore versus ₹230 crore, UP 20.8%

    • EBITDA at ₹480 crore versus ₹437.9 crore, UP 9.6%

    • Margin at 18% versus 21%

    May 22, 2025, 15:20 PM

  9. Unichem Lab Q4: Consolidated net profit at ₹53 crore

    • Revenue at ₹587.2 crore versus ₹459.6 crore, UP 27.8% YoY.

    • Net profit at ₹53 crore profit versus ₹136.7 crore loss.

    May 22, 2025, 15:11 PM

  10. Emcure Pharma Q4: Consolidated net profit surges over 64% YoY

    • Revenue at ₹2,116 crore versus ₹1,771.3 crore, UP 19.5%.

    • Net profit at ₹189 crore versus ₹115 crore, UP 64.4%.

    May 22, 2025, 15:02 PM

  11. Sun Pharma Q4: How have the shares fared

    Sun Pharma shares have given subdued returns to investors so far in 2025. The stock is down over 8.5% this year and 6% in May 2025. US trade tariff threats have impacted the Sun Pharma stock performance.

    EBITDA margin is expected to improve on the back of higher sales of the Revlimid, gRevlimid, and Taro pharm drug and sustained growth in domestic formulations.

    May 22, 2025, 14:46 PM

  12. Sun Pharma Q4 results today

    Pharma major, Sun Pharmaceutical Industries, will announce its March quarter results today. The results are expected to be announced after market hours followed by analyst/ investor meeting.

    In the December (Q3FY25) quarter, Sun Pharma registered a consolidated net profit of ₹2,913 crore, up 13% YoY, while its revenue from operations stood at ₹13,675 crore, up 10% YoY during the same period. The company reported revenue of ₹11,983 crore in Q4FY24 and net profit of ₹2,659 crore.

    May 22, 2025, 14:36 PM

  13. Strides Pharma Q4: Dividend recommendation for Q4

    The pharma company's board has recommended a final dividend of ₹4 per equity share of ₹10 each (at the rate of 40%) for the financial year ending March 31, 2025. "Dividends will be paid within 30 days from the date of shareholders’ approval at the ensuing Annual General Meeting (AGM)," Strides Pharma said.

    May 22, 2025, 14:04 PM

  14. Strides Pharma Q4: Consolidated net profit quadruples to ₹82.19 crore YoY

    • Revenue at ₹1,190.39 crore versus ₹1,043.50 crore, UP 14.1%

    • Net profit at ₹82.19 crore versus ₹18.18 crore, UP 352%

    • EBITDA at ₹217.86 crore versus ₹204.32 crore, UP 7%

    • Margin at 18.3% versus 19.6%

    May 22, 2025, 13:46 PM

  15. Clean Science Q4: Dividend recommended for FY25

    The company's board has recommended a final dividend of ₹4 (400%) per equity share of the face value of ₹1 each for the financial year ending March 31, 2025. "The final dividend is subject to the approval of the members at the ensuing Annual General Meeting, which will be held within the stipulated timeline as per the provisions of the Companies Act, 2013," the firm said.

    May 22, 2025, 13:14 PM

  16. Clean Science Q4: Consolidated net profit rises 6% YoY

    • Revenue at ₹263.6 crore versus ₹227.5 crore, UP 15.8%.

    • Net profit at ₹74.09 crore versus ₹70.2 crore, UP 5.7%.

    • EBITDA at ₹105 crore versus ₹95 crore, UP 10.6%.

    • Margin at 39.8% versus 41.7%

    May 22, 2025, 13:00 PM

  17. ITC Q4: Technical view

    The technical structure of the ITC remains weak as it trades below its 200-day exponential moving average (EMA) for five months. Additionally, it is facing resistance from the downward sloping trendline connecting its all-time high and January siwng high.

    For the upcoming sessions, short-term traders can monitor the price action around 200-day EMA and 50-day EMA. A close above or below these levels supported by the candlestick pattern will provide further directional clues. Read more

    May 22, 2025, 12:53 PM

  18. ITC Q4 preview: Net profit likely to fall

    The FMCG major ITC is expected to report mixed earnings, with low single-digit revenue growth and a decline in net profit. Experts believe ITC is likely to post a 1–3% year-on-year (YoY) increase in standalone revenue, reaching ₹16,500–₹16,850 crore. This growth is expected to be driven by higher sales in its FMCG and cigarettes segments.

    However, profitability may be under pressure. Net profit is projected to decline 6–8% YoY to ₹4,600–₹4,700 crore, largely due to margin compression from rising raw material costs.

    May 22, 2025, 12:44 PM

  19. Q4 results on May 22: Check list

    • Accedere
    • Adishakti Loha and Ispat
    • Adroit Infotech
    • Advance Multitech
    • Advance Petrochemicals
    • AKI India
    • Aksh Optifibre
    • Alankit
    • Alexander Stamps and Coin
    • Archidply Industries
    • Aries Agro
    • Ashiana Agro Industries
    • Asia Pack
    • Astra Microwave Products
    • Bajel Projects
    • Barbeque-Nation Hospitality
    • Bharat Gears
    • Bloom Industries
    • Blue Coast Hotels
    • BSL
    • Cargosol Logistics
    • Centum Electronics
    • Chowgule Steamships
    • Clean Science and Technology
    • Capital Trade Links
    • DAPS Advertising
    • Deepak Fertilisers & Petrochemicals Corporation
    • Deepak Spinners
    • Dhunseri Tea & Industries
    • Dwarikesh Sugar Industries
    • Eldeco Housing & Industries
    • Emami Realty
    • Emerald Finance
    • Emerald Leisures
    • Expleo Solutions
    • Fervent Synergies
    • Flair Writing Industries
    • Gandhar Oil Refinery (India)
    • Geetanjali Credit and Capital
    • Gujarat Industries Power Company
    • GOCL Corporation
    • Golden Carpets
    • Goodluck India
    • Grasim Industries
    • Graviss Hospitality
    • Greenpanel Industries
    • Growington Ventures India
    • Gujarat State Petronet
    • Haryana Capfin
    • HFCL
    • Hindustan Motors
    • HLV
    • HPL Electric & Power
    • Hubtown
    • India Finsec
    • Igarashi Motors India
    • India Gelatine & Chemicals
    • Indo Amines
    • Indoco Remedies
    • Indus Finance
    • Integra Switchgear
    • Investment & Precision Castings
    • Iykot Hitech Toolroom
    • Jai Mata Glass
    • Jay Bharat Maruti
    • Jet Solar
    • Jigar Cables
    • JSL Industries
    • Jupiter Infomedia
    • Kabsons Industries
    • Kaira Can Company
    • Kiran Syntex
    • Kriti Industries India
    • Kriti Nutrients
    • Kronox Lab Sciences
    • Labelkraft Technologies
    • Lincoln Pharmaceuticals

    May 22, 2025, 12:27 PM

  20. Q4 earnings updates: Check the list firms to declare March quarter earnings today

    As many as 164 companies will post their earnings number for the fourth quarter of the financial year 2024-25 on Thursday, May 22. This includes Container Corporation of India (CONCOR), Emcure Pharmaceuticals, GMR Airports, Honasa Consumers, ITC Ltd, Max Estates, The Ramco Cements, Reliance Home Finance, Sun Pharmaceuticals and Strides Pharma Science.

    May 22, 2025, 12:21 PM